| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 376 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 372 |
| 2 | TACROLIMUS OINTMENT 0.1% | 372 |
| 3 | MYCOPHENOLATE MOFETIL | 257 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 257 |
| 5 | PREDNISONE | 254 |
| 6 | PREDNISOLONE | 125 |
| 7 | PREDNISOLONE ORAL | 125 |
| 8 | PREDNISOLONE ORAL SOLUTION | 125 |
| 9 | METHYLPREDNISOLONE | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 9 | 0.0063 |
| 1 | ITRACONAZOLE | 40 | 0.0034 |
| 2 | ANIDULAFUNGIN | 5 | 0.0031 |
| 3 | TACROLIMUS OINTMENT 0.1% | 372 | 0.0029 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 372 | 0.0029 |
| 5 | BELATACEPT | 13 | 0.0027 |
| 6 | BELUMOSUDIL | 8 | 0.0024 |
| 7 | TACROLIMUS | 376 | 0.0024 |
| 8 | AMPHOTERICIN B LIPOSOME | 5 | 0.0021 |
| 9 | MYCOPHENILIC ACID | 45 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 407 |
| 1 | Azole Antifungal [EPC] | 103 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 45 |
| 3 | Purine Antimetabolite [EPC] | 39 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 19 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| 7 | Polyene Antifungal [EPC] | 17 |
| 8 | Kinase Inhibitor [EPC] | 16 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 9 | 0.0063 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 13 | 0.0027 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 45 | 0.0021 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 5 | Allylamine Antifungal [EPC] | 5 | 0.0007 |
| 6 | Azole Antifungal [EPC] | 103 | 0.0007 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 12 | 0.0006 |
| 8 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 8 | 0.0006 |